Manufacturer with High Quality and Competitive Price
Commercial Supply Dapoxetine Hydrochloride and Related Intermediates:
3-Chloropropiophenone CAS: 936-59-4
(S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4
(S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8
(R)-Diphenylprolinol CAS: 22348-32-9
(S)-Diphenylprolinol CAS: 112068-01-6
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1
(R)-(+)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-33-0
3-Chloro-1-Phenyl-1-Propanol CAS: 18776-12-0
Dapoxetine CAS: 119356-77-3
Dapoxetine Hydrochloride CAS: 129938-20-1
| Chemical Name |
3-Chloropropiophenone |
| Synonyms |
3-Chloro-1-Phenyl-1-Propanone |
| CAS Number |
936-59-4 |
| CAT Number |
RF-PI152 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C9H9ClO |
| Molecular Weight |
168.62 |
| Condition to Avoid |
Moisture Sensitive |
| Melting Point |
46.0~50.0℃ |
| Boiling Point |
147℃/14 mmHg |
| Solubility (Soluble in) |
Methanol |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
White Crystals or White Powder |
| Purity / Analysis Method |
≥99.5% (GC) |
| Phenyl Acetone |
≤0.10% |
| 2-Chloropropiophenone |
≤0.10% |
| 4'-Chloropropiophenone |
≤0.10% |
| 3'-Bromopropiophenone |
≤0.10% |
| 3,5-Dichlorobenzene Acetone |
≤0.10% |
| 3,4'-Dichloropropiophenone |
≤0.10% |
| Single Unknown Impurity |
≤0.10% |
| All Unknown Impurities |
≤1.0% |
| Moisture (K.F) |
≤0.50% |
| Test Standard |
Enterprise Standard |
| Usage |
Dapoxetine Hydrochloride Pharmaceutical Intermediates |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 3-Chloropropiophenone (CAS: 936-59-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis.
3-Chloropropiophenone (CAS: 936-59-4) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1).
Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men.